News

devdiscourse31m
Vinay Prasad's Surprising Return to Lead FDA's Biologics Division
Prasad's time at the FDA has been fraught with controversy, especially surrounding the regulation of a gene therapy for Duchenne muscular dystrophy, which was linked to the deaths of two teenagers.
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
Doncaster Free Press on MSN6h
Mum's cycling challenge fundraising for ‘Declan’s Muscle Mission’ inspired by son, 11, who lives with Duchenne muscular dystrophy
Last month Claire Ellis, aged 34, a teacher from Doncaster, set off from her home to cycle 100km in support of her son Declan ...
CT Insider on MSN8h
Winsted woman with muscular dystrophy plays power soccer, wants to form CT team
Power soccer brought Dana Parrott freedom; now she’s on a mission to bring the sport to Connecticut. Earlier this year, ...
Cumberland Pharmaceuticals’ Earnings Call Highlights Growth and Expansion
Detailed price information for Cumberland Pharmaceu (CPIX-Q) from The Globe and Mail including charting and trades.
The Malaysian Reserve14h
SRPT INVESTOR NOTICE: Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: ...